-
K. Reinhart,
F.M. Brunkhorst, H.-G. Bone,
J. Bardutzky,
C.-E. Dempfle,
H. Forst,
P. Gastmeier,
H. Gerlach,
M. Gründling,
S. John, [......],
M. Quintel,
M. Ragaller,
R. Rossaint,
H. Seifert,
C. Spies,
F. Stüber,
N. Weiler,
A. Weimann,
K. Werdan,
T. Welte
Intensivmedizin + Notfallmedizin 04/2012; 47(3):185-207.
-
K. Reinhart,
F. M. Brunkhorst, H.-G. Bone,
H. Gerlach,
M. Gründling,
G. Kreymann,
P. Kujath,
G. Marggraf,
K. Mayer,
A. Meier-Hellmann,
C. Peckelsen,
C. Putensen,
F. Stüber,
M. Quintel,
M. Ragaller,
R. Rossaint,
N. Weiler,
T. Welte,
K. Werdan
[show abstract]
[hide abstract]
ABSTRACT: Nach neuesten Erhebungen des vom BMBF geförderten Kompetenznetzwerkes Sepsis (SepNet) erkranken in Deutschland pro Jahr 75
000 Einwohner (110 von 100 000) an einer schweren Sepsis bzw. septischem Schock und 79 000 (116 von 100 000) an einer Sepsis.
Mit ca. 60 000 Todesfällen stellen septische Erkrankungen die dritthäufigste Todesursache nach dem akuten Myokardinfarkt dar.
Die direkten anteiligen Kosten, die allein für die intensivmedizinische Behandlung von Patienten mit schwerer Sepsis anfallen,
liegen bei ca. 1,77 Milliarden Euro. Ca. 30% des Budgets für Intensivmedizin werden damit in die Behandlung der Sepsis investiert.
Im Kontrast hierzu, existierten bisher jedoch keine deutsche Leitlinien zur Diagnose und Therapie der schweren Sepsis. Auf
Initiative der Deutschen Sepsis-Gesellschaft wurden daher in Anlehnung an die internationalen Empfehlungen des International
Sepsis Forum (ISF) und der Surviving Sepsis Campaign (SSC) Leitlinien erarbeitet, welche die Versorgungsstrukturen im deutschen
Gesundheitssystem berücksichtigen. Folgende Leitlinienthemen wurden als vorrangig eingestuft: a) Diagnose, b) Prävention,
c) kausale Therapie, d) supportive Therapie, e) adjunktive Therapie. Die Leitlinien sind nach einem sorgfältig geplanten und
streng eingehaltenen Prozess nach den Vorgaben der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
(AWMF) entstanden.
A recent survey conducted by the publicly funded Competence Network Sepsis (Sep- Net) reveals that severe sepsis and/or septic
shock occurs in 75,000 inhabitants (110 out of 100,000) and sepsis in 79,000 inhabitants (116 out of 100,000) in Germany annually.
This illness is responsible for approx. 60,000 deaths and ranges as the third most frequent cause of death after acute myocardial
infarction. Direct costs for the intensive care of patients with severe sepsis alone amount to approx. 1.77 billion euros,
which means that about 30% of the budget in intensive care is used to treat severe sepsis. However, until now German guidelines
for the diagnosis and therapy of severe sepsis did not exist. Therefore, the German Sepsis Society initiated the development
of guidelines which are based on international recommendations by the International Sepsis Forum (ISF) and the Surviving Sepsis
Campaign (SSC) and take into account the structure and organisation of the German health care system. Priority was given to
the following guideline topics: a) diagnosis, b) prevention, c) causative therapy, d) supportive therapy, e) adjunctive therapy.
The guidelines development process was carefully planned and strictly adhered to according to the requirements of the Working
Group of Scientific Medical Societies (AWMF).
Clinical Research in Cardiology 04/2012; 95(8):429-454. · 2.95 Impact Factor
-
K Reinhart,
F M Brunkhorst, H-G Bone,
J Bardutzky,
C-E Dempfle,
H Forst,
P Gastmeier,
H Gerlach,
M Gründling,
S John, [......],
M Quintel,
M Ragaller,
R Rossaint,
H Seifert,
C Spies,
F Stüber,
N Weiler,
A Weimann,
K Werdan,
T Welte
Der Anaesthesist 04/2010; 59(4):347-70. · 0.99 Impact Factor
-
K Reinhart,
F M Brunkhorst, H-G Bone,
J Bardutzky,
C-E Dempfle,
H Forst,
P Gastmeier,
H Gerlach,
M Gründling,
S John, [......],
M Quintel,
M Ragaller,
R Rossaint,
H Seifert,
C Spies,
F Stüber,
N Weiler,
A Weimann,
K Werdan,
T Welte
[show abstract]
[hide abstract]
ABSTRACT: Practice guidelines are systematically developed statements and recommendations that assist the physicians and patients in making decisions about appropriate health care measures for specific clinical circumstances taking into account specific national health care structures. The 1(st) revision of the S-2k guideline of the German Sepsis Society in collaboration with 17 German medical scientific societies and one self-help group provides state-of-the-art information (results of controlled clinical trials and expert knowledge) on the effective and appropriate medical care (prevention, diagnosis, therapy and follow-up care) of critically ill patients with severe sepsis or septic shock. The guideline had been developed according to the "German Instrument for Methodological Guideline Appraisal" of the Association of the Scientific Medical Societies (AWMF). In view of the inevitable advancements in scientific knowledge and technical expertise, revisions, updates and amendments must be periodically initiated. The guideline recommendations may not be applied under all circumstances. It rests with the clinician to decide whether a certain recommendation should be adopted or not, taking into consideration the unique set of clinical facts presented in connection with each individual patient as well as the available resources.
German medical science : GMS e-journal 01/2010; 8:Doc14.
-
K Reinhart,
F M Brunkhorst, H-G Bone,
H Gerlach,
M Gründling,
G Kreymann,
P Kujath,
G Marggraf,
K Mayer,
A Meier-Hellmann,
C Peckelsen,
C Putensen,
F Stüber,
M Quintel,
M Ragaller,
R Rossaint,
N Weiler,
T Welte,
K Werdan
[show abstract]
[hide abstract]
ABSTRACT: A recent survey conducted by the publicly funded Competence Network Sepsis (Sep- Net) reveals that severe sepsis and/or septic shock occurs in 75,000 inhabitants (110 out of 100,000) and sepsis in 79,000 inhabitants (116 out of 100,000) in Germany annually. This illness is responsible for approx. 60,000 deaths and ranges as the third most frequent cause of death after acute myocardial infarction. Direct costs for the intensive care of patients with severe sepsis alone amount to approx. 1.77 billion euros, which means that about 30% of the budget in intensive care is used to treat severe sepsis. However, until now German guidelines for the diagnosis and therapy of severe sepsis did not exist. Therefore, the German Sepsis Society initiated the development of guidelines which are based on international recommendations by the International Sepsis Forum (ISF) and the Surviving Sepsis Campaign (SSC) and take into account the structure and organisation of the German health care system. Priority was given to the following guideline topics: a) diagnosis, b) prevention, c) causative therapy, d) supportive therapy, e) adjunctive therapy. The guidelines development process was carefully planned and strictly adhered to according to the requirements of the Working Group of Scientific Medical Societies (AWMF).
Clinical Research in Cardiology 09/2006; 95(8):429-54. · 2.95 Impact Factor
